CloudHealth Announces Genomic Immunotherapy Response Diagnostic

CloudHealth Genomics of Shanghai announced a second genomics-based precision medicine test panel, ImmuneSeq Cancer. ImmuneSeq is a 463-gene panel that profiles human response to immunotherapies in all cancer types, with the goal of accelerating drug discovery, therapies and predictive biomarkers. Earlier this year, CloudHealth launched its first panel, HealthySeq, a whole genome next generation sequencing liquid biopsy for healthy individuals. HealthySeq establishes a genomic baseline for an individual and alerts doctors to disease predisposition. More details.... Share this with colleagues: // //